Machine Learning Model Performance Sorted by Decreasing MAE. by Renan N. D. Almeida (9265283)

Subjects:

Summary of predictors that increase (+ UC) and decrease (- UC) the dose of propofol for the three statistical models used for data analysis. by Chiara E. Hampton (16484687)

Subjects:

Task variability/correlations decrease independently of mean task activity removal step in fMRI data. by Takuya Ito (57473)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

Depleted antibody secreting cells did not result in decreased donor specific antibody in non-sensitized animals. by Natalie M. Bath (6316517)

“…(A) T (CD3⁺) and (B) B (CD45R⁺) cell flow crossmatch was performed in non-sensitized animals. IgG1⁺ in the T cell flow crossmatch was the only DSA that BLyS^-/- significantly decreased compared to APRIL^-/- (p<0.03). …”

Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Homozygous microdeletions of SNPs in the rs58923657 non-risk haplotype result in significantly decreased <i>IKZF1</i> expression and increased proliferation in human LCLs. by Vincent U. Gant (9955199)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

CFU-Mk is significantly decreased by GATA1s overexpression in <i>GATA1s</i> strains. by Shiori Matsuo (10492159)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

“…Statistical differences in maximal IFN values between groups are marked by a level of significance (*) estimated based on p-values above the box plots (*, p < 0.05; **, p < 0.005; ***, p < 0.0005; ****, p < 5e-5). …”

Estimated marginal means of the RMS per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Subjects:

Estimated marginal means of the MF per muscle, based on the linear mixed-effects model. by I. Moll (14227650)

Subjects:

Summary results of the logistic regression model M2-12 including the significant two-way interactions to maximise loglikelihood. by Dennis Ochola (11626912)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Impaired Ubr5 function results in increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

Sulfasalazine rank significantly decreases (p = 0.01) from day 2 to day 6 of DSS administration for mice colonic samples from GSE22307. by Lichy Han (294140)

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

DataSheet1_Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine.docx by Liang Zheng (206933)

“…This study aimed to develop a physiologically based pharmacokinetic (PBPK) model of olanzapine in the pregnant population. …”